Susquehanna International Group, LLP Iovance Biotherapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$7.78 - $14.19 $9.26 Million - $16.9 Million	-1,190,700 Reduced 65.82%	618,300 $4.96 Million
Q1 2024 May 07, 2024	BUY	$7.59 - $17.47 $6.08 Million - $14 Million	801,500 Added 79.55%	1,809,000 $26.8 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $1.11 Million - $3 Million	336,900 Added 50.24%	1,007,500 $8.19 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $1.59 Million - $3.15 Million	358,700 Added 115.0%	670,600 $3.05 Million
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $1.14 Million - $1.92 Million	212,100 Added 212.53%	311,900 $2.2 Million
Q1 2023 May 16, 2023	BUY	$5.53 - $8.22 $196,315 - $291,810	35,500 Added 55.21%	99,800 $609,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $2.11 Million - $3.76 Million	-375,800 Reduced 85.39%	64,300 $410,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $233,484 - $321,195	24,500 Added 5.9%	440,100 $4.22 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $739,442 - $2.12 Million	115,900 Added 38.67%	415,600 $4.59 Million
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $2.45 Million - $3.77 Million	-197,600 Reduced 39.73%	299,700 $4.99 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $4.95 Million - $8.26 Million	298,800 Added 150.53%	497,300 $9.49 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $870,980 - $1.14 Million	-42,800 Reduced 17.74%	198,500 $4.9 Million
Q2 2021 Aug 11, 2021	BUY	$16.33 - $33.07 $983,065 - $1.99 Million	60,200 Added 33.24%	241,300 $6.28 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $14 Million - $25.7 Million	-488,000 Reduced 72.93%	181,100 $5.73 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $9.79 Million - $17.5 Million	349,100 Added 109.09%	669,100 $31 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $1.83 Million - $2.4 Million	-66,100 Reduced 17.12%	320,000 $10.5 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $3.16 Million - $4.76 Million	-116,100 Reduced 23.12%	386,100 $10.6 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $2.59 Million - $5.15 Million	132,500 Added 35.84%	502,200 $15 Million
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $4.21 Million - $6.89 Million	234,400 Added 173.24%	369,700 $10.2 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $584,675 - $845,000	32,500 Added 31.61%	135,300 $2.46 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $37,164 - $93,176	-3,800 Reduced 3.56%	102,800 $2.52 Million
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $65,598 - $87,828	7,800 Added 7.89%	106,600 $1.01 Million
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $1.61 Million - $2.56 Million	-214,700 Reduced 68.48%	98,800 $874,000
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $2.34 Million - $3.69 Million	208,400 Added 198.29%	313,500 $3.53 Million
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $742,020 - $1.01 Million	-59,600 Reduced 36.19%	105,100 $1.35 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $903,960 - $2.18 Million	111,600 Added 210.17%	164,700 $2.78 Million
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $263,340 - $366,300	39,600 Added 293.33%	53,100 $425,000
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $60,075 - $115,425	13,500	13,500 $105,000

Others Institutions Holding IOVA

# of Institutions

323

Shares Held

239M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.48B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account